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items (8%). Two different versions of the scale were developed
according to the age of the children. CONCLUSIONS: The
DANN scale is the ﬁrst questionnaire of NRQoL developed in
Europe and can be a useful tool for the evaluation of the effects
of a nutritional intervention in healthy children.
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OBJECTIVES: Investigate the relationship between patients’ val-
uations of their own health using the standard gamble (SG) and
EQ-5D visual analogue scale (VAS) and general population
values of the same health states within the context of a ran-
domised controlled trial to compare alternative treatments for
varicose veins. METHODS: Patients (n = 131) were surveyed at
randomisation and at 12 months to assess their own health status
using the SG. Patients also completed the SF-36 and the EQ-5D
at the same time-points. Responses to the SF-36 were converted
into SF-6D using the SG algorithms developed by Brazier and
colleagues, version one and two, based upon general population
values. RESULTS: At both time points, the SG produced a higher
mean score than either of the SF-6D algorithms although the dif-
ference between patient and general population values was far
more pronounced for version two [Baseline mean (SD) version
one: 0.913 (0.072), version two: 0.730 (0.108), patients’ value
0.942 (0.116); 12 months mean (SD) version one: 0.912 (0.082),
version two: 0.736 (0.108), patients’ value 0.924 (0.115)]. Sim-
ilarly, the VAS produced a higher mean score than either of the
algorithms based upon general population values [Baseline mean
(SD) SF-6D VAS algorithm: 0.668 (0.173), EQ-5D VAS algo-
rithm: 0.743 (0.173), patients’ value 0.762 (0.167); 12 months
mean (SD) SF-6D VAS algorithm: 0.676 (0.191), EQ-5D VAS
algorithm: 0.771 (0.155), patients’ value 0.781 (0.104)]. CON-
CLUSIONS: For the condition of varicose veins, the magnitude
of differences in health state valuations due to treatment appears
to be small compared with the magnitude of differences exhib-
ited between alternative sources of values and the effect of dif-
ferent valuation systems. The variant of elicitation technique
used to elicit SG values may be more important than the source
of those values in revealing discrepancies.
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OBJECTIVES: Treatment satisfaction with medication (TSM), a
patient reported outcome, is an important factor in promoting
patient adherence to prescription regimens. This review evalu-
ates published instruments measuring TSM across various
disease states. METHODS: A systematic literature review of
Medline from 1980–2004 was conducted. Instruments measur-
ing satisfaction with important attributes of treatment, as
opposed to one-item global measures of satisfaction, were
selected for review. The following ﬁelds were abstracted from
articles for each instrument and summarized: applicable disease
state; mode of administration; modules, domains and items;
response options; method used for item development/selection;
psychometric properties; and practicality. Standard psychomet-
ric measures including internal consistency and test-retest relia-
bility, validity and responsiveness were chosen as evaluative cri-
teria. Alpha ≥0.7 was chosen as acceptable for reliability.
RESULTS: Eleven disease-speciﬁc instruments were identiﬁed
(SATQ, PSAM, MTSM, DTSQ, PPMQ, PSIT, EDITS, PSQ, TSS-
IOP, ITSQ, HIVTSQ), in addition to one generic instrument
(TSQM). All these instruments are self-administered but vary
widely in items, domains, and psychometric measures. The
number of items range from eight (DTSQ)–26 (SATQ) and the
number of domains one–eight. All instruments except PSQ and
EDITS were developed through patient reports. All measured
internal consistency. Of the 12 instruments evaluated, only 6
measured test-retest reliability; 3 of the 6 (ITSQ, SATQ, and
PSIT) had domains with low reproducibility (alpha <0.7). Only
PPMQ reported responsiveness. Only MTSM measured patient
expectations at baseline, and expectations, weighted by subjec-
tive importance of symptoms and the actual treatment experi-
ence, were used to derive TSM. CONCLUSIONS: This review
determined that most TSM instruments have acceptable psycho-
metric properties. However, expectations with treatment and
clinical interpretation of change scores are missing from these
measures. Further research is required to develop well-supported
conceptual models of TSM, TSM measures in different thera-
peutic areas, and validation of existing measures in different 
populations.
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OBJECTIVES: Assess the state of the art of the studies on eco-
nomic evaluations in health care in Mexico, regarding their
methodological quality and tendencies. METHODS: Systematic
review of the research on economic evaluation in health pub-
lished in Mexico from January 1983 to July 2004. We searched
multiple electronic databases, hand-searched key journals and
personally contacted investigators in June 2004. Two health
economist reviewers independently assessed the relevante of
retrieved articles, described the methods of included studies and
extrated data that were summarized. Used Drummond criteria;
a) to classify in completes (CEE) or parcial evaluation economic
(PEE), and b) assessment criteria in quality of methodology. The
analysis of the publications characteristics was made with
descriptive statistics. Limitation: Included only published studies
and possible omitted studies subjectivity in judging certain items.
RESULTS: Ninety-six match with inclusion criteria, 24 of them
were CEE, 69 were PEE and 3 were editorials. The number of
CEE in Mexico increased greatly between 1983–1993 (three
studies) and 1994-May 2004 (21 studies). We reviewed 23 CEE
studies in extenso. The technique most used was cost-effective-
ness (83%). In terms of methodological quality the 78% do not
mentioned study perspective, 56.52% do not reported sensitiv-
ity analyses, 58.34% do not reported had used the discount rate
when it was necessary and 60% do not report clearly the costs.
CONCLUSIONS: The study results reveal an increase in CEE in
México in the last ten years, with low quality methodology.
There is a need to elaborate and validate guidelines for economic
evaluation in health for Mexico by uniﬁed quality standards in
order to have internal and external validity.
